مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

331
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

219
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

POLICY, EQUITY AND PRIORITY: ETHICAL ISSUES OF STEM CELL IN DEVELOPING COUNTRIES

Author(s)

 ARDESHIR LARIJANI MOHAMMAD BAGHER | ZAHEDI F. | Issue Writer Certificate 

Pages

  1-11

Abstract

 Ever-increasing advances in the field of bioethics have been encouraged by recent developments of biomedical technologies. STEM CELL research and therapy are among the most promising approaches in medicine of which are raised some ethical challenges. Likewise, the therapeutic potential of STEM CELL-based therapies created new POLICY concerns for health care systems, particularly the issue of EQUITY, priority in resource allocation and justice. There are arguments against and in favor of funding for STEM CELL research. Governments have also diverse policies in encouraging private sector sponsorship to support researches. Iran is one of the pioneers in the field of human embryonic STEM CELL research in the region. The religious decrees permitting therapeutic purposes have paved the way for wide-ranging researches. Indeed, the researchers have an obligation to observe moral values. Therefore, the national specific guideline for gamete and embryo research, compiled in 2005, is followed in this issue. In this paper, we will discuss the major ethical concerns relating to the issue of EQUITY and justice, and will review the regulatory policies for STEM CELL research and therapy. On the whole, STEM CELL research is a global enterprise about which there is a need to think in the context of globalisation and also from the perspective of the developing countries. STEM CELL based therapies are expensive and technologically demanding, the low-resource healthcare systems need to consider a specific national POLICY and to weigh up costs and benefits to consider making such treatments available. We must ensure that rights, values and welfare of the donor, recipient and the community are respected.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    ARDESHIR LARIJANI, MOHAMMAD BAGHER, & ZAHEDI, F.. (2008). POLICY, EQUITY AND PRIORITY: ETHICAL ISSUES OF STEM CELL IN DEVELOPING COUNTRIES. IRANIAN JOURNAL OF PUBLIC HEALTH, 37(1(SUPPLEMENTARY ISSUE ON BIOETHICS)), 1-11. SID. https://sid.ir/paper/272488/en

    Vancouver: Copy

    ARDESHIR LARIJANI MOHAMMAD BAGHER, ZAHEDI F.. POLICY, EQUITY AND PRIORITY: ETHICAL ISSUES OF STEM CELL IN DEVELOPING COUNTRIES. IRANIAN JOURNAL OF PUBLIC HEALTH[Internet]. 2008;37(1(SUPPLEMENTARY ISSUE ON BIOETHICS)):1-11. Available from: https://sid.ir/paper/272488/en

    IEEE: Copy

    MOHAMMAD BAGHER ARDESHIR LARIJANI, and F. ZAHEDI, “POLICY, EQUITY AND PRIORITY: ETHICAL ISSUES OF STEM CELL IN DEVELOPING COUNTRIES,” IRANIAN JOURNAL OF PUBLIC HEALTH, vol. 37, no. 1(SUPPLEMENTARY ISSUE ON BIOETHICS), pp. 1–11, 2008, [Online]. Available: https://sid.ir/paper/272488/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button